DE MARCH, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 171
EU - Europa 161
AS - Asia 108
SA - Sud America 28
AF - Africa 7
Totale 475
Nazione #
US - Stati Uniti d'America 164
RU - Federazione Russa 90
SG - Singapore 52
CN - Cina 26
BR - Brasile 22
IT - Italia 21
GB - Regno Unito 12
CA - Canada 7
DE - Germania 7
SE - Svezia 7
VN - Vietnam 7
FR - Francia 6
HK - Hong Kong 6
AR - Argentina 4
FI - Finlandia 4
IE - Irlanda 4
KR - Corea 4
BE - Belgio 3
IN - India 3
NL - Olanda 3
TR - Turchia 3
ID - Indonesia 2
NG - Nigeria 2
TG - Togo 2
AT - Austria 1
BD - Bangladesh 1
BJ - Benin 1
BO - Bolivia 1
DZ - Algeria 1
EG - Egitto 1
ES - Italia 1
IQ - Iraq 1
JP - Giappone 1
OM - Oman 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
UZ - Uzbekistan 1
Totale 475
Città #
Dallas 71
Moscow 37
Singapore 28
San Jose 19
Ashburn 16
Chandler 11
Los Angeles 7
Southend 7
Beijing 6
Hong Kong 6
São Paulo 6
The Dalles 5
Dublin 4
Montreal 4
Orem 4
Stockholm 4
Verona 4
Brussels 3
Chennai 3
Hanoi 3
Ho Chi Minh City 3
London 3
Munich 3
Turku 3
Vicenza 3
Ankara 2
Belo Horizonte 2
Bologna 2
Castelnuovo del Garda 2
Hebei 2
Jinan 2
Lomé 2
Marseille 2
New York 2
Passos 2
Xi'an 2
Abuja 1
Amsterdam 1
Assis 1
Asunción 1
Avellaneda 1
Bexley 1
Boardman 1
Bonneuil-sur-Marne 1
Bragado 1
Buenos Aires 1
Buffalo 1
Bulungan 1
Cairo 1
Campinas 1
Canoas 1
Cerquilho 1
Charleston 1
Concord 1
Cotonou 1
Erechim 1
Falkenstein 1
Feira de Santana 1
Frankfurt am Main 1
Guangzhou 1
Hassi Bahbah 1
Helsinki 1
Iguape 1
Ilhéus 1
Ipatinga 1
Jardín América 1
Juiz de Fora 1
Lawrence 1
Lombard 1
Muscat 1
Nanchang 1
Osasco 1
Poplar 1
Princeton 1
Redmond 1
Redondo Beach 1
Rolante 1
Sacramento 1
San Francisco 1
San Rafael 1
Santa Cruz 1
Selçuklu 1
Seoul 1
Shenyang 1
St Petersburg 1
Sulaymaniyah 1
Tashkent 1
Tianjin 1
Tokyo 1
Toronto 1
Venice 1
Vienna 1
Windsor 1
Totale 342
Nome #
A successful treatment-free remission is achievable also by chronic myeloid leukemia patients lacking optimal requirements 162
A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients: a report from the Triveneto Myeloma Working Group 160
Cytogenetic Impact on Lenalidomide Treatment in Relapsed/Refractory Multiple Myeloma: A Real-Life Evaluation 158
Totale 480
Categoria #
all - tutte 1.749
article - articoli 1.749
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.498


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202210 0 4 0 1 1 0 0 0 0 0 0 4
2022/202321 1 2 1 6 3 4 0 1 3 0 0 0
2023/202420 0 2 0 0 3 0 0 1 0 1 8 5
2024/202596 3 2 7 16 1 2 12 5 14 6 10 18
2025/2026312 10 61 23 52 69 21 24 15 20 12 2 3
Totale 480